Previous studies indicated that p38/MAPK activation regulated stathmin in cardiomyocytes (Hu et al., 2010) and that p38/MAPK activation affected gallbladder carcinoma cell and inflammatory cell proliferation and migration by regulating stathmin (Wang et al., 2016; Esnault et al., 2020). This evidence concerns the gene STMN1 and gallbladder carcinoma.